METGE DEL RAVAL-ELX: Cost-consequences analysis of natriuretic peptide assays to refute symptomatic heart failure in primary care | The British Journal of Cardiology

miércoles, 10 de diciembre de 2014

Cost-consequences analysis of natriuretic peptide assays to refute symptomatic heart failure in primary care | The British Journal of Cardiology

Cost-consequences analysis of natriuretic peptide assays to refute symptomatic heart failure in primary care | The British Journal of Cardiology

No hay comentarios:

Publicar un comentario

Danos tu opinion, enriquece el post.

Suscribirse a: Enviar comentarios (Atom)